POC Treatment in NTD
POC diagnostics delivers rapid information for patient care. The common platform is the lateral flow immunoassay. Recently, emerging molecular diagnostics have met requirements for speed, low cost, and ease of use for POC applications. A major driver for POC development is the ability to diagnose infectious diseases at sites with a limited infrastructure. The potential use in both wealthy and resource-limited settings has fuelled an intense effort to build on existing technologies and to generate new technologies for the diagnosis of a broad spectrum of infectious diseases. POC diagnostics also reduce the reliance on presumptive treatment and thereby facilitate antibiotic control. Rapid diagnostic tests work by detecting analyte that are found in or extracted from clinical samples. There are two primary types of analytes: microbial antigens and patient antibodies that are specific for microbial antigens. However, there are emerging molecular technologies that enable nucleic acid-based approaches at the POC
- Diagnostic Innovation
- Antimicrobial Resistance
- Mass Drug Administration
- NTD Drugs
- NTD Vector Control Agents
- Disease-Specific Diagnostic Tools
- Personalized POC Testing
Related Conference of POC Treatment in NTD
September 22-23, 2025
11th International Conference on Infectious and Rare Diseases
Vancouver, Canada
October 06-07, 2025
13th World Congress on Control and Prevention of HIV/AIDS, STDs & STIs
Las Vegas, USA
October 30-31, 2025
20th World Conference on Infectious Diseases, Prevention and Control
Paris, France
December 11-12, 2025
8th Annual Congress on Bacterial, Viral and Infectious Diseases
Prague, Czech Republic
December 17-18, 2025
17th Global Conference on Nephrology and Infectious Diseases
Amsterdam, Netherlands
December 22-23, 2025
6th International Conference on Microbiology and Infectious Diseases
Barcelona, Spain
January 22-23, 2026
10th International Conference on Infectious Diseases: Control and Prevention
Aberdeen, UK
May 14-15, 2026
13th International Conference on Infectious Diseases, Bacteriology and Antibiotics
Aix-en-Provence, France
May 18-18, 2026
6th World Congress on Tuberculosis, Lung Infections, and Respiratory Care
Aix-en-Provence, France
POC Treatment in NTD Conference Speakers
Recommended Sessions
- Animal Diseases
- Anti-Microbial Resistance in NTDs
- Current Advancements in NTD
- Emerging Neglected Tropical Diseases
- Global NTD Epidemiology and Challenges
- Neglected Tropical Diseases in Clinical Research
- Orphan Drugs
- POC Treatment in NTD
- Rare Diseases
- Socio-economic impact of NTD
- Tropical Bacterial Diseases
- Tropical Parasitic Diseases
- Tropical Protozoan Diseases
- Tropical Viral Diseases
- Tropical Zoonotic Diseases
- Vaccines for Tropical Diseases
- Water, Sanitation and Hygiene
Related Journals
Are you interested in
- 1.Infectious Diseases and Neuro Infectious Diseases - Infectious Diseases_2025 (Canada)
- 10. HIV/AIDS - Infectious Diseases_2025 (Canada)
- 11. Pediatric Infectious Diseases/ Childhood Infectious Diseases - Infectious Diseases_2025 (Canada)
- 12. Respiratory Diseases - Infectious Diseases_2025 (Canada)
- 13. Sexually Transmitted Diseases/ Sexually Transmitted Infections - Infectious Diseases_2025 (Canada)
- 14. Viral Infectious Diseases - Infectious Diseases_2025 (Canada)
- 15. Malaria and Hepatitis - Infectious Diseases_2025 (Canada)
- 16. Immunology of Infections - Infectious Diseases_2025 (Canada)
- 17. Vaccines and Vaccination - Infectious Diseases_2025 (Canada)
- 18. Tuberculosis - Infectious Diseases_2025 (Canada)
- 19. New Antiviral, Antibacterial and Antifungal Agents - Infectious Diseases_2025 (Canada)
- 2. Coronavirus(nCOV) - Infectious Diseases_2025 (Canada)
- 20. Nosocomial Infections - Infectious Diseases_2025 (Canada)
- 21. Parasitic Diseases - Infectious Diseases_2025 (Canada)
- 22. Surgical Site Infections - Infectious Diseases_2025 (Canada)
- 3. Infectious Diseases Prevention, Control and Cure - Infectious Diseases_2025 (Canada)
- 4. Bacterial & Fungal Infectious Diseases - Infectious Diseases_2025 (Canada)
- 5. Rare Infectious Diseases and Immune Deficiencies - Infectious Diseases_2025 (Canada)
- 6. Rare Diseases in Cancer and Aging - Infectious Diseases_2025 (Canada)
- 7. Global Trends in Emerging Infectious Diseases - Infectious Diseases_2025 (Canada)
- 8. Ebola and Zika Viral Infections - Infectious Diseases_2025 (Canada)
- 9. Clinical Research and Public Awareness - Infectious Diseases_2025 (Canada)
- A prospective study of dermatological infections - Emerging Infectious Diseases 2025 (Canada)
- Alcohol and Drug Use - STD-HIV AIDS-2025 (USA)
- Antimicrobial Resistance - Emerging Infectious Diseases 2025 (Canada)
- Antimicrobial Stewardship/Antimicrobial Resistance - Infection Prevention 2025 (UK)
- Bacterial Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Bacterial, Parasitic and Fungal Infections - Infection Prevention 2025 (UK)
- Blood Borne Infections/Sepsis/Septicaemia - Infection Prevention 2025 (UK)
- Cardiovascular Diseases and Disorders - Emerging Infectious Diseases 2025 (Canada)
- Causes and Symptoms of Infections - Infection Prevention 2025 (UK)
- Causes and Symptoms of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Changing Patterns of Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Clinical and Case Reports - INFECTIOUS DISEASES-2026 (France)
- Clinical Management of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Clinical Research and Case Reports - STD-HIV AIDS-2025 (USA)
- Co-infections Associated with STDs - STD-HIV AIDS-2025 (USA)
- Coronavirus Disease (COVID-19) - INFECTIOUS DISEASES-2026 (France)
- Covid_19 Infections - Infection Prevention 2025 (UK)
- Dental diseases & Infections - Emerging Infectious Diseases 2025 (Canada)
- Diabetes and Wound Care - Emerging Infectious Diseases 2025 (Canada)
- Diagnosis and Treatment - STD-HIV AIDS-2025 (USA)
- Diagnosis of infectious Diseases - Infection Prevention 2025 (UK)
- Diagnostics and Laboratory Techniques - Emerging Infectious Diseases 2025 (Canada)
- Emerging and Re-Emerging Infections - Infection Prevention 2025 (UK)
- Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Epidemiology - Infection Prevention 2025 (UK)
- Epidemiology and Surveillance - Emerging Infectious Diseases 2025 (Canada)
- Fungal Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Gastrointestinal and Urinary Tract Infections - Infection Prevention 2025 (UK)
- Global Climatic Change and Emerging Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Health Security - Emerging Infectious Diseases 2025 (Canada)
- Global hotspots and correlates of emerging zoonotic diseases - Emerging Infectious Diseases 2025 (Canada)
- Global Trends in Emerging Infections - Infection Prevention 2025 (UK)
- Hepatitis Prevention - Infection Prevention 2025 (UK)
- HIV and Women's Health Issues - STD-HIV AIDS-2025 (USA)
- Human Monkeypox: An Emerging Zoonosis - Emerging Infectious Diseases 2025 (Canada)
- Immunizations and Vaccination - Infection Prevention 2025 (UK)
- Infection Control in Critical Care - Infection Prevention 2025 (UK)
- Infection Control Procedures - Infection Prevention 2025 (UK)
- Infection Prevention and Control - Infection Prevention 2025 (UK)
- Infection, Immunity and Inflammation - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases Epidemiology - INFECTIOUS DISEASES-2026 (France)
- Infectious Diseases Prevention, Control and Cure - INFECTIOUS DISEASES-2026 (France)
- Internal Medicine for Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Neuro Infections - Infection Prevention 2025 (UK)
- Neuro Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections & Control - INFECTIOUS DISEASES-2026 (France)
- Nosocomial Infections and Control - Infection Prevention 2025 (UK)
- Nosocomial Infections and Their Control Strategies - Emerging Infectious Diseases 2025 (Canada)
- Outbreak Investigation and Response - Emerging Infectious Diseases 2025 (Canada)
- Parasitology & Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Pediatric HIV - STD-HIV AIDS-2025 (USA)
- Pediatric Infectious Diseases - Emerging Infectious Diseases 2025 (Canada)
- Pediatric Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Perspectives on Gastrointestinal Infections - Emerging Infectious Diseases 2025 (Canada)
- Pharmacology of Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Plants Diseases and Infection Control - Infection Prevention 2025 (UK)
- Public Health - STD-HIV AIDS-2025 (USA)
- Public Health Policy and Preparedness - Emerging Infectious Diseases 2025 (Canada)
- Recent Advancements - STD-HIV AIDS-2025 (USA)
- Research on Medicine and Vaccine for Covid-19 - INFECTIOUS DISEASES-2026 (France)
- Respiratory Infectious Diseases and Therapy - Infection Prevention 2025 (UK)
- SARS and MERS: Recent Insights into Emerging Coronaviruses - Emerging Infectious Diseases 2025 (Canada)
- Sexual Health - STD-HIV AIDS-2025 (USA)
- Sexually Transmitted Diseases - STD-HIV AIDS-2025 (USA)
- Testing and Health Monitoring - STD-HIV AIDS-2025 (USA)
- The Science of SARS-CoV-2 - Emerging Infectious Diseases 2025 (Canada)
- Therapeutics and Treatment Strategies - Emerging Infectious Diseases 2025 (Canada)
- Transmission and Prevention - STD-HIV AIDS-2025 (USA)
- Tropical Infectious Diseases - INFECTIOUS DISEASES-2026 (France)
- Vaccines and Immunization - Emerging Infectious Diseases 2025 (Canada)
- Vaccines and People with HIV - STD-HIV AIDS-2025 (USA)
- Vaccines and Vaccination - INFECTIOUS DISEASES-2026 (France)
- Vector-borne diseases: New Approaches to Control Vector from disease transmission - Emerging Infectious Diseases 2025 (Canada)
- Veterinary Diseases - INFECTIOUS DISEASES-2026 (France)
- Viral Infections and Recent Advancements - Infection Prevention 2025 (UK)
- Viral Infectious Diseases - INFECTIOUS DISEASES-2026 (France)